RPM Devices Transform Patient Monitoring, Show Promise for Reshaping Cancer Care
MedCity News
|
Contributed by: Kate Gamble
Summary
Wearable devices are reshaping cancer care by enabling continuous, real-world monitoring of patients throughout treatment. They provide clinicians with rich streams of biometric data that help gauge fitness levels, track side effects, and predict complications earlier than traditional, episodic check-ins. Systematic reviews involving thousands of patients show high adherence (often over 80%), revealing wearables’ feasibility for treatment monitoring, rehabilitation, and prognostication. Moreover, emerging AI‑driven platforms (e.g., CardioAI for detecting treatment‑induced cardiac risk) promise to integrate wearable data with predictive analytics to catch adverse events preemptively. As evidence mounts, these tools are poised to move oncology toward personalized, proactive care—shifting from reactive visits to near‑real‑time, data-informed interventions.
